Scholarlink

<p>Bacteriocins are underexplored yet promising candidates to combat antimicrobial resistance (AMR) and enable targeted therapy due to their natural origin, abundance and narrow spectrum of activity. In this study, we used a collection of engineered DNA devices and cell-free gene expression (CFE) to rapidly produce combinations (cocktails) of bacteriocins comprising both linear and circular proteins. Other cocktails were designed to target a specific bacterial species by leveraging insights into bacteriocin pathways for cell envelope penetration. These tailored combinations eradicated bacteria effectively while preventing resistance development. The synthesis of bacteriocins was optimized by using continuous exchange CFE, reengineering DNA parts, and adjusting conditions for disulfide bond formation. Also, we illustrate the efficacy of these bacteriocin mixtures against various multidrug-resistant human pathogens and highlight their potential through in vivo testing in the animal model <i>Galleria mellonella</i>. Our bacteriocin cocktail expression and test platform underscores the potential of bacteriocins for innovative treatments against multidrug-resistant infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multiplexed bacteriocin synthesis to combat and prevent antimicrobial resistance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月19日

查看全文
  • Alex Quintero-Yanes,
  • Kenny Petit,
  • Hector Rodriguez-Villalobos,
  • Hanne Vande Capelle,
  • Olivier De Veirman,
  • Hans Gerstmans,
  • Joleen Masschelein,
  • Juan Borrero,
  • Pascal Hols,
  • Philippe Gabant

摘要

Bacteriocins are underexplored yet promising candidates to combat antimicrobial resistance (AMR) and enable targeted therapy due to their natural origin, abundance and narrow spectrum of activity. In this study, we used a collection of engineered DNA devices and cell-free gene expression (CFE) to rapidly produce combinations (cocktails) of bacteriocins comprising both linear and circular proteins. Other cocktails were designed to target a specific bacterial species by leveraging insights into bacteriocin pathways for cell envelope penetration. These tailored combinations eradicated bacteria effectively while preventing resistance development. The synthesis of bacteriocins was optimized by using continuous exchange CFE, reengineering DNA parts, and adjusting conditions for disulfide bond formation. Also, we illustrate the efficacy of these bacteriocin mixtures against various multidrug-resistant human pathogens and highlight their potential through in vivo testing in the animal model Galleria mellonella. Our bacteriocin cocktail expression and test platform underscores the potential of bacteriocins for innovative treatments against multidrug-resistant infections.